Patent assignee · US · COMPANY

Century Therapeutics, Inc.

🏢 View company profile →
4Patents
4Active
4Granted
56Portfolio score

Filing activity: Jul 5, 2019 → Mar 30, 2023

Most-cited patents

PatentTitleAreaCited byStatus
US12269888B2 Artificial cell death polypeptide for chimeric antigen receptor and uses thereof Chemistry; Metallurgy 0 Active
US11661459B2 Artificial cell death polypeptide for chimeric antigen receptor and uses thereof Chemistry; Metallurgy 0 Active
US11401246B2 Triazole glycolate oxidase inhibitors Chemistry; Metallurgy 0 Active
US11883432B2 Chimeric antigen receptor system with adaptable receptor specificity Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.